DonaldRoweLanninMD
General Surgery • New Haven, CTBreast, Surgical Oncology (Other than Breast)
Professor of Surgery, Yale University
Dr. Lannin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Howard Ave Lowr Level
Yale Physicians Building
New Haven, CT 06519Phone+1 203-785-3577Fax+1 203-737-4033
Education & Training
University of MinnesotaResidency, Surgery, 1974 - 1982- University of Minnesota Medical SchoolClass of 1974
Certifications & Licensure
CT State Medical License 2002 - 2025
NC State Medical License 1982 - 2012
MN State Medical License 1976 - 2005- American Board of Surgery Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors: New York Metro Area Castle Connolly, 2010-2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Join now to see all
Clinical Trials
- A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients Start of enrollment: 2011 Oct 01
Publications & Presentations
PubMed
- AMACR Expression is a Potential Diagnostic Marker in Apocrine Lesions of Breast, and is Associated with High Histologic Grade and Lymph Node Metastases in Some Invasiv...Gabriel Lerner, Haiming Tang, Kamaljeet Singh, Reza Golestani, Samantha St Claire
Clinical Breast Cancer. 2023-02-01 - 4 citationsAssociation of Medicaid Expansion with Post-mastectomy Reconstruction Rates.Justin Le Blanc, Mehra Golshan, Donald Lannin, Rachel Greenup, Elizabeth R Berger
Annals of Surgical Oncology. 2022-04-01 - 1 citationsAuthor Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal Fischbach
NPJ Breast Cancer. 2022-02-03
Authored Content
- Do All Positive Margins in Breast Cancer Patients Undergoing a Partial Mastectomy Need to Be Resected?March 2018
Press Mentions
Connecticut's Top Doctors 2021: Over 1,500 Physicians in 66 SpecialtiesJune 1st, 2021- Neoadjuvant Durvalumab plus Weekly Nab-Paclitaxel and Dose-Dense doxorubicin/cyclophosphamide in Triple-Negative Breast CancerFebruary 8th, 2021
- Yale Study: Breast Cancer Found Earlier in States with Expanded MedicaidJuly 1st, 2020
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
